Exploring Epigenetic Modifications in Huntington's Disease: Implications for Disease Progression and Therapeutic Strategies

Huntington's disease (HD) is a devastating neurodegenerative disorder characterized by a genetic mutation leading to the production of a toxic mutant huntingtin protein. While extensive research has elucidated the genetic underpinnings of HD, a significant research gap remains in understanding the role of epigenetic modifications in disease progression. This paper addresses this critical gap by investigating the impact of epigenetic changes, including DNA methylation and histone modifications, on the variable expressivity and clinical manifestations of HD. International studies have hinted at the importance of epigenetic factors in disease severity, while research in the United States has delved into specific histone marks associated with neuronal dysfunction. The global context lacks comprehensive research on the epigenetic landscape of HD. This study is motivated by the urgent need to bridge this gap, offering insights into potential regional variations in epigenetic modifications that may influence disease progression. The significance of this research lies in its potential to inform targeted therapeutic interventions, contributing to the broader medical field's understanding of HD and offering hope for the development of precision medicine approaches for affected individuals. Through this investigation, we aim to advance the current understanding of HD and pave the way for innovative strategies to mitigate its devastating impact.